ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ ГЛАЗ ПРЕПАРАТОМ ЛЕВОСТАВ

З.Х. Курьязова, Ф.А. Мирбабаева

Передовая Офтальмология · 2023-yil

Annotatsiya

Relevance. We review the issues of pharmaceutical safety of the country in the article. Purpose of the study.Is to evaluate the clinical and laboratory efficiency of the experimental samples of eye drops containing levofloxacin, producedin our Republic and its analogue, manufactured in abroad. Material and methods. Treatment was carried out in 93 patients (131eyes) with inflammatory eye diseases. Two homogeneous groups were formed: the main group – 53 patients (71 eyes) whoreceived instillations of Levostav (0,5% eye drops, manufactured in Uzbekistan) by 2 drops 4 times a day, and the control group– 40 patients (60 eyes), Levoyaps (0,5% eye drops of L-optics Rompharm, manufactured in Romania) by 2 drops 4 times a day.Results and conclusion. The domestic medical drug of the fluoroquinolone series - Levostav, creating high therapeutic dosesin biological tissues, has an evident bactericidal effect that is not inferior in efficiency to foreign analogues. Its application canbe recommended as the medical drug of choice in the treatment and prevention of the inflammatory eye diseases. To preventcases of antibiotic resistance, it is necessary to strengthen the quality control of the drug.

Maqola ma’lumotlari
MualliflarЗ.Х. Курьязова, Ф.А. Мирбабаева
JurnalПередовая Офтальмология
Nashr sanasi2023-04-14
Jild2
Son2
Betlar52-56
Tilru
DOI10.57231/j.ao.2023.2.2.009

Передовая Офтальмология jurnalidan boshqa maqolalar

Передовая Офтальмология — barcha maqolalar